Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 - PubMed (original) (raw)

Review

. 2018 Mar;25(3):486-541.

doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23.

Lorenzo Galluzzi 1 2 3, Stuart A Aaronson 6, John M Abrams 7, Dieter Adam 8, Patrizia Agostinis 9, Emad S Alnemri 10, Lucia Altucci [ 11](#full-view-affiliation-11 "Department of Biochemistry, Biophysics and General Pathology, University of Campania "Luigi Vanvitelli", Napoli, Italy."), Ivano Amelio 12, David W Andrews 13 14 15, Margherita Annicchiarico-Petruzzelli 16, Alexey V Antonov 12, Eli Arama 17, Eric H Baehrecke 18, Nickolai A Barlev 19, Nicolas G Bazan 20, Francesca Bernassola [ 21](#full-view-affiliation-21 "Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy."), Mathieu J M Bertrand 22 23, Katiuscia Bianchi 24, Mikhail V Blagosklonny 25, Klas Blomgren 26 27, Christoph Borner 28 29, Patricia Boya 30, Catherine Brenner 31 32, Michelangelo Campanella [ 4](#full-view-affiliation-4 "Department of Biology, University of Rome "Tor Vergata", Rome, Italy.") 5 33 34, Eleonora Candi 16 [ 21](#full-view-affiliation-21 "Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy."), Didac Carmona-Gutierrez 35, Francesco Cecconi [ 4](#full-view-affiliation-4 "Department of Biology, University of Rome "Tor Vergata", Rome, Italy.") 36 37, Francis K-M Chan 38, Navdeep S Chandel 39, Emily H Cheng 40, Jerry E Chipuk 6, John A Cidlowski 41, Aaron Ciechanover 42, Gerald M Cohen 43, Marcus Conrad 44, Juan R Cubillos-Ruiz 45 46, Peter E Czabotar 47 48, Vincenzo D'Angiolella 49, Ted M Dawson 50 51 52 53, Valina L Dawson 50 51 53 54, Vincenzo De Laurenzi [ 55](#full-view-affiliation-55 "Department of Medical, Oral and Biotechnological Sciences, CeSI-MetUniversity of Chieti-Pescara "G. d'Annunzio", Chieti, Italy."), Ruggero De Maria [ 56](#full-view-affiliation-56 "Institute of General Pathology, Catholic University "Sacro Cuore", Rome, Italy."), Klaus-Michael Debatin 57, Ralph J DeBerardinis 58, Mohanish Deshmukh 59, Nicola Di Daniele [ 60](#full-view-affiliation-60 "Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy."), Francesco Di Virgilio 61, Vishva M Dixit 62, Scott J Dixon 63, Colin S Duckett 64, Brian D Dynlacht 65 66, Wafik S El-Deiry 67 68, John W Elrod 69, Gian Maria Fimia [ 70](#full-view-affiliation-70 "National Institute for Infectious Diseases IRCCS "Lazzaro Spallanzani", Rome, Italy.") 71, Simone Fulda 72 73 74, Ana J García-Sáez 75, Abhishek D Garg 9, Carmen Garrido [ 76](#full-view-affiliation-76 "INSERM U1231 "Lipides Nutrition Cancer", Dijon, France.") 77 78, Evripidis Gavathiotis 79 80 81 82, Pierre Golstein 83, Eyal Gottlieb 42 84, Douglas R Green 85, Lloyd A Greene 86, Hinrich Gronemeyer [ 87](#full-view-affiliation-87 "Team labeled "Ligue Contre le Cancer", Department of Functional Genomics and Cancer, Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France.") 88 89 90, Atan Gross 91, Gyorgy Hajnoczky 92, J Marie Hardwick 93, Isaac S Harris 94, Michael O Hengartner 95, Claudio Hetz 96 97 98, Hidenori Ichijo 99, Marja Jäättelä 100, Bertrand Joseph 101, Philipp J Jost 102, Philippe P Juin [ 103](#full-view-affiliation-103 "Team 8 "Stress adaptation and tumor escape", CRCINA-INSERM U1232, Nantes, France.") 104 105 106, William J Kaiser 107, Michael Karin 108 109 110 111, Thomas Kaufmann 112, Oliver Kepp 113 114 115 [ 116](#full-view-affiliation-116 "Team 11 labeled "Ligue Nationale contre le Cancer", Cordeliers Research Center, Paris, France.") 117 118, Adi Kimchi 17, Richard N Kitsis 80 81 82 119 120, Daniel J Klionsky 121 122, Richard A Knight 12, Sharad Kumar 123, Sam W Lee 124, John J Lemasters 125 126, Beth Levine 127 128 129, Andreas Linkermann 130, Stuart A Lipton 131 132 133, Richard A Lockshin 134 135, Carlos López-Otín 136, Scott W Lowe 137 138, Tom Luedde 139, Enrico Lugli 140 141, Marion MacFarlane 12, Frank Madeo 35 142, Michal Malewicz 12, Walter Malorni 143, Gwenola Manic [ 4](#full-view-affiliation-4 "Department of Biology, University of Rome "Tor Vergata", Rome, Italy.") 5, Jean-Christophe Marine 144 145, Seamus J Martin 146, Jean-Claude Martinou 147, Jan Paul Medema 148 149, Patrick Mehlen 150 [ 151](#full-view-affiliation-151 "Team labeled "La Ligue contre le Cancer", Lyon, France.") 152 153 154 155, Pascal Meier 156, Sonia Melino 157, Edward A Miao 158 159 160, Jeffery D Molkentin 161, Ute M Moll 162, Cristina Muñoz-Pinedo 163, Shigekazu Nagata 164, Gabriel Nuñez 165 166, Andrew Oberst 167 168, Moshe Oren 169, Michael Overholtzer 170, Michele Pagano 66 171 172, Theocharis Panaretakis 173 174, Manolis Pasparakis 175 176, Josef M Penninger 177, David M Pereira 178, Shazib Pervaiz 179 180 181, Marcus E Peter 182 183, Mauro Piacentini [ 4](#full-view-affiliation-4 "Department of Biology, University of Rome "Tor Vergata", Rome, Italy.") [ 70](#full-view-affiliation-70 "National Institute for Infectious Diseases IRCCS "Lazzaro Spallanzani", Rome, Italy."), Paolo Pinton 61 184 185, Jochen H M Prehn 186, Hamsa Puthalakath 187, Gabriel A Rabinovich 188 189, Markus Rehm 190 191, Rosario Rizzuto 192, Cecilia M P Rodrigues 193, David C Rubinsztein 194, Thomas Rudel 195, Kevin M Ryan 84, Emre Sayan 196, Luca Scorrano 197 198, Feng Shao 199, Yufang Shi 200 201 202, John Silke 48 203, Hans-Uwe Simon 112, Antonella Sistigu [ 56](#full-view-affiliation-56 "Institute of General Pathology, Catholic University "Sacro Cuore", Rome, Italy.") 204, Brent R Stockwell 205 206, Andreas Strasser 47, Gyorgy Szabadkai 192 207 208, Stephen W G Tait 84, Daolin Tang 209 210 211 212 213 214, Nektarios Tavernarakis 215, Andrew Thorburn 216, Yoshihide Tsujimoto 217, Boris Turk [ 218](#full-view-affiliation-218 "Department Biochemistry and Molecular Biology, "Jozef Stefan" Institute, Ljubljana, Slovenia.") 219, Tom Vanden Berghe 22 23, Peter Vandenabeele 22 23, Matthew G Vander Heiden 220 221 222, Andreas Villunger 223, Herbert W Virgin 224, Karen H Vousden 208, Domagoj Vucic 225, Erwin F Wagner 226, Henning Walczak 227, David Wallach 228, Ying Wang 229, James A Wells 230, Will Wood 231, Junying Yuan 94 232, Zahra Zakeri 233, Boris Zhivotovsky 101 234, Laurence Zitvogel 114 235 236 237, Gerry Melino 12 [ 21](#full-view-affiliation-21 "Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy."), Guido Kroemer 238 239 240 [ 241](#full-view-affiliation-241 "Team 11 labeled "Ligue Nationale contre le Cancer", Cordeliers Research Center, Paris, France. kroemer@orange.fr.") 242 243 244

Affiliations

Review

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

Lorenzo Galluzzi et al. Cell Death Differ. 2018 Mar.

Abstract

Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing financial interests.

Figures

Fig. 1

Fig. 1

Major cell death subroutines. Mammalian cells exposed to unrecoverable perturbations of the intracellular or extracellular microenvironment can activate one of many signal transduction cascades ultimately leading to their demise. Each of such regulated cell death (RCD) modes is initiated and propagated by molecular mechanisms that exhibit a considerable degree of interconnectivity. Moreover, each type of RCD can manifest with an entire spectrum of morphological features ranging from fully necrotic to fully apoptotic, and an immunomodulatory profile ranging from anti-inflammatory and tolerogenic to pro-inflammatory and immunogenic. ADCD: autophagy-dependent cell death, ICD: immunogenic cell death, LDCD: lysosome-dependent cell death, MPT: mitochondrial permeability transition.

Fig. 2

Fig. 2

Interconnectivity of cell death from a therapeutic perspective. On the basis of the assumption that each regulated cell death (RCD) subroutine would operate in a virtually isolated manner (a), considerable efforts have been dedicated to the development of pharmacological agents that would interrupt RCD by operating on a single signal transduction module (b). It is now clear that the molecular mechanisms underlying distinct RCD modalities exhibit a considerable degree of interconnectivity (c). This implies that robust cytoprotection may not be achieved by targeting a single RCD subroutine, but only upon the simultaneous inhibition of multiple signal transduction modules (assuming that these modules are the actual cause of cell death, and not simple epiphenomena of RCD signaling (d).

Fig. 3

Fig. 3

Causal vs. accessory aspects of cell death from a therapeutic perspective. Cells exposed to very harsh environmental conditions disassemble in a virtually instantaneous and uncontrollable manner, a process that is referred to as accidental cell death (ACD). Conversely, relatively mild perturbations of exogenous or endogenous origin promote adaptative stress responses aimed at the restoration of cellular homeostasis. If such responses fail, cells generally activate one or more of multiple, highly interconnected signal transduction modules that precipitate regulated cell death (RCD). ACD cannot be retarded by pharmacological or genetic interventions, and most (if not all) strategies conceived so far to block RCD in mammalian organisms fail to efficiently do so, at least in part owing to the elevated interconnectivity of the process. Conversely, some agents that de facto promote RCD by primarily targeting the underlying molecular machinery (rather than by targeting normal cellular functions) are already available for use in the clinic. The events that follow primary cell death—including a secondary wave of RCD in neighboring cells established (directly or indirectly) by molecules released from the cells succumbing to the primary insult, as well as danger-associated molecular pattern (DAMP) signaling—may also be targets for pharmacological interventions. Finally, although altering quantitatively the percentage of cells succumbing to primary RCD remains challenging (especially when a hitherto poorly defined point-of-no-return of the process has been trespassed), favoring the use of specific signaling modules over others may have prominent effects on long-term disease outcome.

Similar articles

Cited by

References

    1. Conrad M, et al. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2016;15:348–66. doi: 10.1038/nrd.2015.6. - DOI - PMC - PubMed
    1. Weinlich R, et al. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2017;18:127–36. doi: 10.1038/nrm.2016.149. - DOI - PubMed
    1. Fuchs Y, et al. Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nat Rev Mol Cell Biol. 2015;16:329–44. doi: 10.1038/nrm3999. - DOI - PMC - PubMed
    1. Pasparakis M, et al. Necroptosis and its role in inflammation. Nature. 2015;517:311–20. doi: 10.1038/nature14191. - DOI - PubMed
    1. Galluzzi L, et al. Regulated cell death and adaptive stress responses. Cell Mol Life Sci. 2016;73:2405–10. doi: 10.1007/s00018-016-2209-y. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources